Hoped for start dates may have been to keep every one ready. I assume every time they get some feedback from any of the 4 regulators represents a potential delay from a hoped for start. At one point they seemed ready to start other trials prior to L SAP finalization then seemed to reconsider. If endpoints can be used that link benefit to predetermined DC cell characteristics then future trials will end quickly based on these newer endpoints. This is what I envision anyway and would be worth the wait to expand usage and application to multiple cancers much more quickly. Getting L to patients quickly is jyst one consideration if Direct trials csn be sped up as well. This is why this must all be done right the first time. Jesus once said "You have turned my Father's house into a den of thieves" and then turned the money changers tables over and drove them out of the area they were in. Later the "authorities" asked Jesus by what authority he had done this because they did not want to understand. NWBO will present irrefutable evidence that some do not want to understand and the tables will turn upside down on the money changers. NWBO and Dr Linda Liau seem ready to demonstrate their authority by way of this SAP and trial results. Best wishes.
News 
Market Data 
Discover 
AI
